158 related articles for article (PubMed ID: 37249004)
1. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
[TBL] [Abstract][Full Text] [Related]
2. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
[TBL] [Abstract][Full Text] [Related]
3. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
[TBL] [Abstract][Full Text] [Related]
5. A Case of severe mosquito bite allergy complicated by fatal hemophagocytic lymphohistiocytosis.
Dupuy E; Afifi L; Jonas SJ; Cheng CE; Hogeling M
Pediatr Dermatol; 2022 May; 39(3):443-446. PubMed ID: 35322460
[TBL] [Abstract][Full Text] [Related]
6. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
[TBL] [Abstract][Full Text] [Related]
7. Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.
Chen CC; Chang KC; Medeiros LJ; Lee JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297336
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
9. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
10. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
[TBL] [Abstract][Full Text] [Related]
11. Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review.
Wang X; Wang P; Wang A; Xu Y; Wang L; Chen Z
BMC Infect Dis; 2021 Jan; 21(1):17. PubMed ID: 33407199
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
Park S; Ko YH
J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells.
Hirai Y; Iwatsuki K; Takahashi T; Miyake T; Nakagawa Y; Tanimoto S; Kawakami Y; Morizane S
Int J Hematol; 2023 Jul; 118(1):54-64. PubMed ID: 37133637
[TBL] [Abstract][Full Text] [Related]
16. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to mosquito bites: A versatile Epstein-Barr virus disease with allergy, inflammation, and malignancy.
Yamada M; Ishikawa Y; Imadome KI
Allergol Int; 2021 Oct; 70(4):430-438. PubMed ID: 34334322
[TBL] [Abstract][Full Text] [Related]
18. Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection.
Grześk E; Kołtan S; Dąbrowska A; Urbańczyk A; Małdyk J; Małkowski B; Bogiel T; Dębski R; Czyżewski K; Wysocki M; Styczyński J
Front Immunol; 2022; 13():915986. PubMed ID: 35990691
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
20. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China.
Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M
J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
